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Abstract
Mutations in the WNK1 gene, encoding a serine-threonine kinase of the WNK (With No lysine (K)) family, have been
implicated in two rare human diseases, Familial Hyperkalemic Hypertension (FHHt) and Hereditary Sensory and Autonomic
Neuropathy type 2 (HSAN2). Alternative promoters give rise to a ubiquitous isoform, L-WNK1, and a kidney-specific isoform,
KS-WNK1. Several other isoforms are generated through alternative splicing of exons 9, 11 and 12 but their precise tissue
distribution is not known. Two additional exons, 8b and HSN2, involved in HSAN2, are thought to be specifically expressed
in the nervous system. The purpose of this study was to establish an exhaustive description of all WNK1 isoforms and to
quantify their relative level of expression in a panel of human and mouse tissues and in mouse nephron segments. For the
latter purpose, we developed a new methodology allowing the determination of the proportions of the different isoforms
generated by alternative splicing. Our results evidenced a striking tissue-specific distribution of the different isoforms and
the unexpected presence of exon HSN2 in many tissues other than the nervous system. We also found exon 26 to be
alternatively spliced in human and identified two new exons, 26a and 26b, within intron 26, specifically expressed in
nervous tissues both in humans and mice. WNK1 should therefore no longer be designated as a 28- but as a 32-exon gene,
with 8 of them - 8b, HSN2, 9, 11, 12, 26, 26a and 26b - alternatively spliced in a tissue-specific manner. These tissue-specific
isoforms must be considered when studying the different roles of this ubiquitous kinase.
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Introduction
WNK1 (With No lysine (K) 1) is a serine threonine kinase of the
WNK family, which comprises 4 members (WNK1 to WNK4).
Large deletions of the first intron of the WNK1 gene are implicated
in Familial Hyperkaliemic Hypertension (FHHt), a rare autosomal
dominant disease characterized by a dysfunction of the distal
nephron [1]. The majority of studies conducted to date have
focused on its role in the kidney [2]. However, WNK1 is
ubiquitous and recent studies have started to highlight its functions
in extrarenal tissues (for review, see [3]). WNK1 plays a major role
in cardiovascular tissues both in the adult mouse, where it
regulates vasoconstriction in response to a1-adrenergic receptors
[4], and in the mouse embryo, where it participates in arterio-
venous specification [5,6]. In addition, in vitro studies clearly
implicate WNK1 in cell migration, division and differentiation
[7,8], possibly through the MAP kinase pathway [8,9], and large
scale sequencing studies have shown a link between somatic
mutations of WNK1 and several types of cancer [10,11,12].
Finally, mutations in exon HSN2 of WNK1, located within intron
8, are responsible for a form of congenital insensitivity to pain,
HSAN2 (Hereditary Sensory and Autonomic Neuropathy type 2)
[13]. Exon HSN2 is described as being exclusively expressed in the
nervous system, associated with another exon named 8b in some
transcripts [13], but the role of the protein sequence encoded by
8b and HSN2 is unknown.
WNK1 is encoded by a very large gene located on human
chromosome 12, which spans over 160 kb and has so far been
considered as containing 28 exons. It gives rise to multiple isoforms
that may explain the different roles of the kinase. Alternative
promoters control the expression of L- and KS-WNK1 [14,15],
which stand for Long and Kidney-Specific WNK1 respectively. L-
WNK1, with its transcript starting at exon 1, is ubiquitously
expressed under the control of proximal promoters [14]. KS-
WNK1 is a shorter kinase-deficient isoform as its transcription
starts at exon 4a, replacing the first 4 exons which encode most of
the kinase domain. It is highly and specifically expressed in the
Distal Convoluted Tubule (DCT) and Connecting Tubule (CNT)
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WNK1 is also subjected to alternative splicing [3]. Exons 11 and 12
are alternatively spliced in human and mouse as well as exon 9 in
human only [14,15,16], but the pattern of expression of the
corresponding transcripts has not been examined in detail.
In this study, we first sought to identify all alternatively spliced
exons of WNK1. We confirmed the splicing of exons 9, 11, 12, 8b
and HSN2 and identified exon 26 and two new exons, 26a and
26b, as novel alternatively spliced exons of WNK1. We then
established the pattern of expression of these 8 alternatively spliced
exons in a panel of human and mouse tissues and developed a new
methodology to quantify the proportion of each WNK1 isoform in
each tissue of interest. We thus show that the different isoforms
display a striking tissue-specificity, which is partially conserved
between human and mouse. When investigating the multiple roles
of WNK1 in the different tissues, it now appears that one must
take into account the tissue-specific isoforms of the kinase.
Results
A new procedure for the quantification of WNK1 isoforms
The aim of our study was not only to define the pattern of
expression of all WNK1 transcripts generated by alternative
splicing but also to estimate precisely how much of each isoform is
present in a given tissue. Relative quantification with Real Time
Quantitative RT-PCR (RT-QPCR) using the classical 2
2DDCT
method allows the determination of the pattern of expression of a
given gene in a panel of tissues or the comparison of its level of
expression between two conditions, with one tissue or condition
used as a calibrator [17]. However, it does not allow the
comparison of the level of expression of two transcripts in a given
tissue or condition, in our case two WNK1 isoforms. In order to
circumvent this limitation, we developed a new analytical
procedure, described in detail in the Methods section, which
allowed us to determine the relative proportions of each WNK1
isoform in a panel of human and mouse tissues using RT-QPCR.
Briefly, we used a ‘‘never-spliced’’ exon of WNK1 as a reference,
instead of a classical housekeeping gene. Then, following the
simple principle that the sum of all WNK1 isoforms in a tissue
equals the level of expression of a ‘never-spliced’ WNK1 exon, in
our case exon 8, we wrote equations in order to determine the real
proportions of WNK1 isoforms. The values obtained for all
WNK1 isoforms in both human and mouse are given in the
subsequent figures and Tables S1, S2, S3.
Pattern of expression of L-and KS-WNK1 in human and
mouse
Most data about the pattern of expression of WNK1 come from
northern blot analyses performed with commercial multi-tissues
blots, including those identifying the ubiquitous distribution of L-
WNK1 and the kidney specific expression of KS-WNK1
[14,15,16,18]. We further characterized the tissue distribution of
these two isoforms by quantifying their expression using RT-
QPCR on a large panel of human and mouse tissues (Figure 1A
and B). Surprisingly, in both species, the strongest expression of L-
WNK1 is seen in the spinal cord. In brain, cerebellum, dorsal root
ganglia (DRG), skeletal muscle, heart, aorta and lung, the
expression is fairly strong in both species. The expression of L-
WNK1 is weaker in the kidney and diminishes further in the
colon. In both species, the lowest expression of L-WNK1 is seen in
the liver. Our results confirm that the expression of KS-WNK1 is
restricted to the kidney.
Expression of L-and KS-WNK1 was further characterized
within the mouse kidney, in microdissected nephron segments
(Figure 1C and Table S3). RT-QPCR confirmed that L-WNK1 is
expressed all along the nephron at similar levels, except for a
higher expression in the glomerulus and a lower expression in the
DCT. In contrast, our analysis revealed that KS-WNK1
expression pattern is broader than previously reported. Its main
sites of expression are the DCT and CNT. In the DCT, KS-
WNK1 represents 99% of WNK1 isoforms and is expressed 80
times more than L-WNK1. In the CNT, KS-WNK1 represents
64% of WNK1 isoforms, respectively, but its expression level is 6
times less than in the DCT. KS-WNK1 is also the predominant
isoform in the cTAL (64% of WNK1 isoforms), even though it is
expressed 16 times less than in the DCT. Finally, KS-WNK1 is
expressed at a very low level in the mTAL and CCD (50 to 65
times less than in the DCT), where it represents between 35 and
40% of WNK1 isoforms. In order to rule out that the low
expression seen in the segments adjacent to the DCT is due to a
contamination of these segments preparations by DCTs, we
performed a RT-QPCR on the same preparations with primers
recognizing the DCT-specific NaCl co-transporter NCC. As
expected, NCC transcripts were detected only in the DCT
preparations (Figure S1), thus showing that cDNAs from DCT do
not contaminate other segments.
Identification of three alternative splicing regions in
WNK1
In order to identify regions likely to be alternatively spliced, we
combined three screening methods. First, we reviewed all relevant
articles in the MEDLINE database; second, we screened the EST
database for transcripts resulting from alternative splicing and,
third, we amplified overlapping regions of WNK1 mRNA by RT-
PCR. This allowed us to determine three regions of interest. The
first is located between exons 8 and 10 and contains three
alternative exons - 8b, HSN2, and 9 (Figure 2). The second,
located between exons 10 and 13, contains two alternative exons -
11 and 12 (Figure 3). The third region, located between exons 25
and 27, has never been studied before. Our results show that exon
26 is alternatively spliced and identify two novel alternative exons,
26a and 26b (Figure 4).
Exons 8b, HSN2 and 9
Three exons are submitted to alternative splicing in the region
located between exons 8 and 10. Exon 9 is spliced out of roughly
half of the transcripts in all human tissues (Figure 2A). This
splicing event does not occur in mice. Transcripts containing the
remaining two, exons 8b and HSN2, were previously cloned and
sequenced in mouse tissues [13], where they were described as
specifically expressed in the nervous system. Our study confirms
that the highest expression of HSN2 is observed in the mouse
dorsal root ganglia (DRG) and spinal cord, where it is present in
57% of WNK1 isoforms (Figure S1). However, its expression is not
restricted to the nervous system. RT-PCR performed on the
mDCT cell line, isolated from mouse DCT [19], showed that
HSN2 expression outside the nervous system cannot be attributed
solely to tissue innervations (Figure 2B). The HSN2-containing
WNK1 protein, WNK1/HSN2, is also detected in the mouse
kidney (Figure 2C). KS-WNK1 appears to contain exon HSN2 as
well, as a PCR product is amplified between exons 4a and HSN2
(data not shown). This is further confirmed by quantification of the
alternative exons in the different nephron segments, which shows
that the expression of HSN2, even though very weak, follows that
of the combination of L- and KS-WNK1, with a low level of
expression along the kidney and a higher expression in the DCT
(Figure S2). We show that exon 8b is only included when HSN2 is
present and that its expression in mice is predominantly detected
WNK1 Isoforms in Human and Mouse
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aorta also contain this exon, a level comparable to that of the
cerebellum.
In human, HSN2-containing transcripts are also expressed
ubiquitously, with a much higher level of expression in the dorsal
root ganglia, where 57% of WNK1 transcripts contain this exon
(Figure 2A). WNK1/HSN2 represent only 3% of WNK1 isoforms
in the spinal cord in human, thus demonstrating that the very
strong expression of L-WNK1 in this tissue (Figure 1) is not due to
the expression of this isoform. Exon 9 is always present in the
Figure 1. Level of expression of L-WNK1 and KS-WNK1 mRNA in a panel of human and mouse tissues. (A) Upper panel: Schematic
representation of the WNK1 gene. The proximal promoter (pP) drives the transcription of L-WNK1. The renal promoter (rP) controls the expression of
KS-WNK1, whose transcription starts at exon 4a (white box), specific to this isoform. Expression of L-WNK1 was quantified by RT-QPCR using primers
recognizing exons 2–3 in humans (lower panel in A) and 1–2 in mice (B). Expression of KS-WNK1 was quantified by RT-QPCR using primers
recognizing exons 4a-5. ubc was used as a reference gene. The expression level of L-WNK1 was arbitrarily set to 1 in the kidney. Panel C presents the
data obtained in microdissected mouse nephron segments using RPL26 as a reference gene. The expression level of L-WNK1 was arbitrarily set to 1 in
the DCT. Glom: glomerulus -PCT: Proximal Convoluted Tubule - cPR:cortical Pars Recta – mPR:medullary Pars Recta – mTAL: medullary Thick
Ascending Limb of Henle’s loop – cTAL: cortical Thick Ascending Limb of Henle’s loop – DCT: Distal Convoluted Tubule – CNT: Connecting tubule –
CCD: cortical Collecting Duct – OMCD: Outer Medullary Collecting Duct. Expression of L-WNK1 is arbitrarily set to 1 in the kidney (B) and in the DCT (C)
and expression of KS-WNK1 is expressed relatively to L-WNK1, the ratio of KS-WNK1 over L-WNK1 being obtained as described in the method section.
doi:10.1371/journal.pone.0037751.g001
WNK1 Isoforms in Human and Mouse
PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e37751WNK1/HSN2 isoform. Even though a genomic sequence highly
homologous to that of mouse exon 8b can be found in the human
genome database, we could not detect expression of this exon in
human tissues, either by RT-PCR or RT-QPCR.
Exons 11 and 12
In both humans and mice, exons 11 and 12 are subjected to
alternative splicing. Exon 11 can be spliced alone (‘‘D11’’ isoform)
or together with exon 12 (‘‘D11–12’’ isoform) but exon 12 (‘‘D12’’
isoform) is rarely spliced alone (Figure 3). Indeed, the ‘‘D12’’
isoform is expressed at very low levels in all tissues examined,
except in the heart in both species and the skeletal muscle in
human.
Each isoform shows a very specific pattern of expression
(Figure 3 and Figure S3). The isoform including both exons
(‘‘complete’’ isoform) is expressed only in the heart, the skeletal
muscle and neural tissues in both species but the level of expression
differs between species. A very high expression of this isoform is
observed in the human heart, where it represents 73% of all
WNK1 isoforms, while it represents 30–48% of WNK1 isoforms
in every aforementioned tissue in mice. ‘‘D11–12’’ is the
predominant isoform in the aorta, particularly in human (69%
and 52% of all WNK1 isoforms in human and mouse
respectively).
The major isoform expressed in the kidney is ‘‘D11’’, which
represents ,70% of WNK1 renal transcripts in both humans and
mice. Exon 12 is the most abundant alternatively spliced exon in
the nephron (Figure S3C). In order to determine if this exon is
included in L-WNK1 and/or KS-WNK1, we calculated the ratio
of exon 12 over exon 8 to estimate the proportion of transcripts
containing this exon in each nephron segment (Figure S3D). This
ratio is similar in all nephron segments (,80%), whether they
express L-WNK1 only, such as the proximal tubules, or a large
majority of KS-WNK1, such as the DCT (Figure S3D). This
indicates that (1) 80% of L-WNK1 transcripts contain exon 12 in
the segments expressing only L-WNK1 and (2) that 80% of KS-
Figure 2. Pattern of expression and relative proportions of the human splice variants of region 8–10. (A) Upper panel: schematic
representation of the different splicing events that can occur in this region. Lower panel: relative quantities of these variants in a panel of human
tissues, expressed as a percentage of total WNK1 expression. Cereb.: Cerebellum; Sp. cord: spinal cord; DRG: Dorsal Root Ganglia; Sk. m.: Skeletal
muscle. (B) A HSN2-containing WNK1 transcript is expressed in mDCT cells. RT-QPCR was performed between exon 8 and HSN2, resulting in the
amplification of a 228 bp fragment (arrow), corresponding to the ‘‘D8b’’ isoform, and a 486 bp fragment (arrowhead), corresponding to the complete
isoform. RNA extracts from mouse brain, expressing both isoforms, and from mouse kidney, expressing mostly the ‘‘D8b’’ isoform, were used as
control. The weak band indicated by an asterisk results from a non-specific amplification (verified by sequencing). (C) The HSN2-containing proteini s
detected in the mouse kidney. Immunoblot of various mouse tissues incubated with an antibody directed against the portion of the protein encoded
by HSN2. A strong signal is detected in the spinal cord and a lower signal in the brain and renal cortex. An immunoblot incubated with a HSP90
antibody shows equal loading of the different samples.
doi:10.1371/journal.pone.0037751.g002
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WNK1 is predominant. However, we cannot draw a conclusion
about L-WNK1 transcripts in those segments as L-WNK1 is
expressed at a very low level compared to KS-WNK1, particularly
in the DCT where L-WNK1 represents only 1.5% of all WNK1
transcripts.
Exons 26, 26a and 26b
We identified for the first time the region between exons 25 and
27 as a region of interest concerning alternative splicing (Figure 4
and Figure S4). The amplification of WNK1 mRNA between
exons 25 and 27 revealed, as expected, a band corresponding to
the full length transcript (exons 25–26–27). The rare splicing of
exon 26 could also be detected, but only in human. In neural
tissues and skeletal muscle, we also detected PCR products longer
than expected. Sequencing of these products revealed the
existence of two new exons within intron 26 of WNK1, which we
named 26a and 26b. While HSN2 does not appear to be specific
to the nervous system, exons 26a and 26b are exclusively expressed
in neural tissues and skeletal muscle. In both species, 26b can be
present alone, especially in the central nervous system, whereas
26a is only present together with 26b. Exons 26a and 26b, 100%
conserved between mouse and human, are respectively 72 and 42
nucleotides long. Their presence does not induce the appearance
of a frameshift or a stop codon.
Discussion
Careful examination of the different isoforms of WNK1
revealed a much more complex situation than initially suspected
[3]. Of the 28 usually described exons of WNK1 [16], four in
humans (9, 11, 12 and 26) and two in mice (11 and 12) are
subjected to alternative splicing. Because of its later discovery,
exon 4a was not initially included in the 28 exons of WNK1.
WNK1 contains four other exons: exons 8b and HSN2, discovered
in the nervous system [13], and exons 26a and 26b, described here
for the first time. Our study not only revealed the complex pattern
of WNK1 isoforms but also allowed the quantification of each
isoform in a panel of human and mouse tissues.
Relative quantification with RT-QPCR, based on the 2
2DDCT
formula or the efficiency-corrected formula [20], is the most
commonly used method to establish the pattern of expression of a
given gene in different tissues or experimental conditions, with one
tissue or condition used as a calibrator [17]. However, our goal
was not only to establish the pattern of expression of WNK1
isoforms, but also to quantify the proportions of these isoforms in
each tissue of interest. We developed a new methodology to
analyze data from RT-QPCR in the case of multiple isoforms
generated from one gene. This technique is a simple and
inexpensive tool to quantify alternative splicing. Noteworthy, this
methodology can also be extended to compare the expression of
different genes as long as they share a 100% homologous region
which can be used as a reference gene. This will often be the case
for homologous genes.
The inclusion or deletion of any combination of the WNK1
alternative exons does not generate a frameshift or a stop codon.
WNK1 is a large 250 kDa protein and the prediction of the
potential role of these exons is difficult in the absence of a three-
dimensional model of the WNK1 protein structure, as only the
crystal structure of the kinase domain has been determined [21].
Computational tools do not predict motifs in these exons, which
does not exclude their potentially important role in protein
structure/function. This is obvious in the case of HSN2, as its
mutated form leads to loss of pain perception, even though no
functional motif can be identified.
Figure 3. Pattern of expression and relative proportions of the human splice variants of region 10–13. Upper panel: schematic
representation of the different splicing events that can occur in this region. Lower panel: relative quantities of these variants in a panel of human
tissues, expressed as a percentage of total WNK1 expression.
doi:10.1371/journal.pone.0037751.g003
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containing transcript by PCR in non-neuronal tissues. Why this
band was not detected previously [13] is not clear. While the
authors did report a band in the kidney, they attributed this to
contamination by adrenal tissue. In our case, kidney dissection was
clear of adrenal tissue and the detection of HSN2 could not be
attributed to the innervations of the kidney since we were able to
amplify the same HSN2 transcript in different renal epithelial cell
lines. These results do not diminish the crucial role of WNK1/
HSN2 in the nervous system but opens the possibility that this
isoform might have a function outside the nervous system.
Interestingly, we observed a particularly high level expression of
HSN2-containing transcripts in the human dorsal root ganglia,
confirming the study conducted in mice [13].
One limitation of our study is that we considered all the studied
tissues as a whole, the only exception being the kidney. All these
tissues contain different cell types, which may express different
WNK1 isoforms. This means that an isoform which is highly
expressed in only one cell type could appear as a minor isoform in
the whole tissue. For instance, there is only a two-fold difference
between KS-WNK1 and L-WNK1 in the whole kidney, whereas
KS-WNK1 is 80-times more expressed than L-WNK1 in DCT
cells. Since WNK1 function has been mostly studied in the kidney,
we focused on this tissue but the same could be true in others.
HSN2-containing transcripts in the dorsal root ganglia may
represent 100% of all transcripts in the satellite cells that envelop
sensory neurons [13]. Similarly, the strong expression observed in
the cerebellum probably results from an especially high expression
in the granular layer and Purkinje cells [22], with fairly weak
expression elsewhere.
These complex and tissue-specific alternative splicing events
must be taken into account when interpreting some of the
previously published data. For instance, alternative splicing of
exon 12 is of particular importance as the main study which
localized WNK1 by immunohistochemistry used an antibody
against the portion of the protein encoded by exon 12 [23]. More
Figure 4. Pattern of expression and relative proportions of the human splice variants of region 25–27. (A) Upper panel: schematic
representation of the different splicing events that can occur in this region. Lower panel: relative quantities of these variants in a panel of human
tissues, expressed as a percentage of total WNK1 expression. (B) DNA and amino acid sequences of exons 26, 26a and 26b. Sequences of exon 26a
and 26b are respectively underlined and in bold.
doi:10.1371/journal.pone.0037751.g004
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isoforms of WNK1, none of the numerous studies conducted in
Xenopus oocytes or cell lines has ever discussed which transcript was
used and the transcript has never been adapted to the organ
studied. Most in vitro studies on the function of WNK1 were
performed with the rat isoform cloned by the laboratory of M.
Cobb [18], which happens to be the ‘‘D11–12’’ isoform. To our
knowledge, no renal study has been conducted with the isoform
expressed specifically in this organ, i.e. the ‘‘D11’’ isoform. Such a
detailed analysis has recently been reported for WNK3, the
alternative splicing of which generates four different transcripts,
with some being specifically expressed in the nervous system. If a
first study concluded that brain and kidney WNK3 isoforms have
opposite effects on NCC [24], a more recent and exhaustive study
reported that all WNK3 transcripts display similar activities
toward the co-transporters of the SLC12 family [25].
In conclusion, WNK1 is a complex 32 exon-gene with multiple
tissue-specific isoforms. Exons 8b, HSN2, 26a and 26b are newly
identified alternatively spliced exons that may play a crucial role,
as has already been demonstrated for HSN2. To be exhaustive,
one should also add exon 4a, discovered a few years after the
kinase was first cloned, making the total exon number 33. Of the
classically described 28 exons of the gene, 4 are also alternatively
spliced, namely exons 9, 11, 12 and 26. In total, 9 WNK1 exons
are alternatively spliced, some expressed in a tissue-specific
manner like exon 4a in the kidney and exons 26a and 26b in
the nervous system, some expressed in all tissues investigated, with
different preferential expressions like exon 11 in the heart and
exon HSN2 in the neural tissues, and some expressed ubiquitously
with no preferential expression, such as exons 9 and 26. The
complexity of this gene must be taken into account in future
studies of both the renal and extra-renal roles of WNK1.
Materials and Methods
Total RNA from mouse and human tissues
All mouse studies were performed in accordance with the
French government animal policy (agreement number 75–1254).
Total RNA was extracted from mouse tissues (4 C57Bl/6N 3
month-old males) using the NucleospinH RNA II extraction kit
(Macherey-Nagel) according to the manufacturer’s instructions.
Human total RNA extracts from various tissues were purchased
from BD Clontech.
RT-PCR and DNA sequence analysis
Total RNA was treated with DNase (DnaseI, Ambion) and
reverse transcribed using Superscript II reverse transcriptase and
Random Primers (Life Technologies
TM). Alternative splicing was
explored with primers complementary to non-spliced exons
flanking the region of interest. The sequence of all primers used
in this study is given in Table S4. The amplified fragments were
visualized by electrophoresis on agarose gels. PCR products
differing from the expected size were purified and subcloned into
pGEMH-T (Promega) and sequenced using the Sanger method
(GATC Biotech). The sequence of the complete human WNK1
coding sequence, containing exons HSN2, 26a and 26b, was
deposited in Genbank (Accession number: JQ358908).
Real-time quantitative RT-PCR
Real-time quantitative RT-PCR (RT-QPCR) was carried out
using intercalation of SYBR green (qPCR MasterMix Plus for
SYBRH; Eurogentec) on a Chromo4 continuous fluorescence
detector (MJ Research, Bio-Rad laboratories, Waltham, MA).
Human or mouse cDNA was serially diluted by 1/5 to generate
standard curves. Primers were used only if the efficiency calculated
from the standard curves was 260.05 and if the melting curve
showed a single peak. No amplification was detected in samples
that did not undergo reverse transcription.
Two reference genes, 18S and GAPDH for human tissue, 18s
and ubiquitin C (ubc) for mouse tissue, and ubc and RPL26 for mouse
nephron segments were tested. Both reference genes gave similar
results and the reference gene with the most stable expression (18S
for human, ubc for mouse tissues and RPL26 for nephron segments)
was chosen to establish the pattern of expression of L- and KS-
WNK1 in the tissue panel or nephron segments, using the 2
2DDCT
formula with the kidney or the DCT arbitrarily fixed as a
calibrator. L-WNK1 expression was quantified using primers
recognizing exons 1 and 2 (mouse) or 2 and 3 (human). KS-
WNK1 expression was quantified using primers recognizing exons
4a (specific of KS-WNK1, Figure 1A) and 5. To examine WNK1
isoforms generated by alternative splicing, we designed primer
pairs to overlap exons that are contiguous only in the isoform of
interest (Figure S5).
Determination of the relative quantities of WNK1
isoforms in a given tissue
As described in the Results section, the relative quantification
using the 2
2DCT formula [17] does not indicate the real ratio of
the gene of interest over the reference gene. For each couple of
primers, the correction factor that would give the real value of this
ratio is unknown and therefore the relative quantity of two
transcripts in a given sample cannot be determined. We
circumvented this limitation by developing a methodology to
determine the correction factor which, applied to the 2
2DCT ratio,
gives the real ratio of the level of expression of the gene of interest
over the reference gene.
The conditions needed to apply our method are the following:
1. a portion of the mRNA that is common to all isoforms must be
determined and used as a internal reference gene.
2. primers should be designed to recognize specifically mutually
exclusive isoforms (as illustrated in the case of region 10–13 in
Figure S5).
3. The RT-QPCR should be run in at least as many tissues or
conditions as there are different isoforms.
The following equations can then be written in every sample:
X
i~1,n
½isoform i ~1
X
i~1,n
ai½isoform i Q~1
where [isoform i] is the ‘‘true’’ expression ratio of isoform i relative
to the reference gene, and ½isoform i Q is the ratio given by the
2
2DCT formula, where DCT is the difference in threshold cycles
for isoform i and the reference gene (CTi2CTref) (see detailed
formula below), which must be corrected by a factor ai that is a
priori unknown.
½isoform i Q~
2CTref
2CTi ~2CTref-CTi~2{DCT
The n correction factors are determined using a simple algorithm
run in C++ that calculates the average and the standard deviation
WNK1 Isoforms in Human and Mouse
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P
i~1,n
ai½isoform i Q in all analysed tissues for all
possible combinations of ai, with a minimal increment of 0.1 from
0.1 to 10. A filter is applied to the results stored in a MySQL
database to retrieve the combination of correction factors (a1 to
an) that yields a value of S between 0.98 and 1.02 in the $n
tissues, with the lowest relative standard deviation. This combi-
nation is then used to determine the true fraction of each isoform
in each tissue.
Noteworthy, the correction factors determined by the equations
include adjustment for the length of the amplicon, so there is no
need to take that factor into account [26] when using our method.
Our methodology applied to the results obtained using a formula
that included the efficiency of the PCR reactions [20,26], or using
values derived from a standard curve yielded the same results,
which is not surprising since the primers were only used if the
corresponding efficiency was very close to 2, a condition necessary
for the validity of the 2
2DDCT formula [17]. Results obtained for
all WNK1 isoforms in both human and mouse are given in Tables
S1, S2, S3. The unknown correction factors yield a sum of
approximately 1 (or 100%) in each of the examined tissues, which
validates our approach. The intrinsic imprecision of RT-QPCR,
mainly due to pipetting inaccuracy, explains the fact that the sum
of isoforms in each tissue is not exactly equal to 100%. Indeed, the
same RT-QPCR experiment performed several times always gives
slightly different results, with a precision of about 10% in our
hands, explaining why the standard deviation of the means of the
sums is around 5–10% for each isoform, and is expected to be
higher when more isoforms are examined.
Example of L-WNK1 and KS-WNK1. Assuming that the
sum of the ‘‘true’’ KS-WNK1-to-exon 8 expression ratio (denoted
by [KS-WNK1]) and the ‘‘true’’ L-WNK1-to-exon 8 expression
ratio (denoted by [L-WNK1]) is equal to 1 (or 100%), we have in
every tissue:
½KS{WNK1 z½L{WNK1 ~1
As described above, the ratios obtained by RT-QPCR (denoted
½KS{WNK1 Q and ½L{WNK1 Q) must be pondered by
correction factors, such that:
a½KS{WNK1 Qzb½L{WNK1 Q~1
where a and b are a priori unknown. These factors were
determined as described above. The original and corrected values
are given in Table S3.
RT-QPCR on microdissected mouse nephron segments
Glomeruli and nephron segments from 6 C57Bl/6 adult males
were characterized and microdissected from liberase-treated
kidneys under a binocular microscope as previously described
[27,28]. After microdissection, pools of tubules of identical
structures from a single mouse were thoroughly rinsed and total
RNA was extracted using the RNeasyH Micro Kit (Qiagen).
Reverse transcription was performed simultaneously for all
samples using the First-strand cDNA Synthesis kit for RT-PCR
(Roche Diagnostics) and Real-time QPCR was performed on a
LightCycler (Roche Diagnostics) with the LightCycler FastStart
DNA Master SYBR Green 1 kit (Roche Diagnostics) as previously
described [28].
Immunoblotting
Preparation of renal cortex, brain and spinal cord total protein
extracts from mouse tissues and immunoblotting was performed as
previously described [29]. The antiWNK1/HSN2 antibody was a
gift of G. Rouleau (Montreal, Canada).
Supporting Information
Figure S1 Verification of the absence of contamination
of the microdissected segments preparations by the
DCT. The expression of the DCT-specific NaCl co-transporter
NCC was quantified in the different nephron segments by RT-
QPCR, using RPL26 as a reference gene. Datas are means 6 s.e.m
from 6 mice. The expression level was arbitrarily fixed set to 100
in the DCT. Glom: glomerulus -PCT: Proximal Convoluted
Tubule - cPR:cortical Pars Recta – mPR: medullary Pars Recta –
mTAL: medullary Thick Ascending Limb of Henle’s loop – cTAL:
cortical Thick Ascending Limb of Henle’s loop – DCT: Distal
Convoluted Tubule – CNT: Connecting tubule – CCD: cortical
Collecting Duct – OMCD: Outer Medullary Collecting Duct.
(PDF)
Figure S2 Pattern of expression and relative propor-
tions of the splice variants of region 8–10 in mice. (A)
Schematic representation of the different splicing events that can
occur in this region. (B) Relative quantities of these variants in a
panel of mouse tissues, expressed as a percentage of total WNK1
expression. Cereb.: Cerebellum; Sp. cord+DRG: Spinal cord+
Dorsal Root Ganglia; Sk. muscle: Skeletal muscle. Unlike the
human situation, exon 9 is always included in the mouse WNK1
mRNA, which could also contain an additional exon, 8b. (C)
Expression level of exons 8b, HSN2 and 11 in microdissected
mouse nephron segments, relative to RPL26. Exon 11 was
included to highlight the low expression of exons 8 h and HSN2,
compared to exon 12, described in Figure S3C. Datas are means
6 s.e.m from 6 mice.
(PDF)
Figure S3 Pattern of expression and relative propor-
tions of the splice variants of region 10–13 in mice. (A)
Schematic representation of the different splicing events that can
occur in this region. (B) Relative quantities of these variants in a
panel of mouse tissues, expressed as a percentage of total WNK1
expression. (C) Expression level of exons 11 and 12 in
microdissected mouse nephron segments, relative to RPL26.
Datas are means 6 s.e.m from 6 mice. (D) Relative quantity of
WNK1 transcripts containing exon 12 in microdissected mouse
nephron segments, calculated as the ratio of exon 12 over exon 8.
(PDF)
Figure S4 Pattern of expression and relative propor-
tions of the splice variants of region 25–27 in mice. Upper
panel: schematic representation of the different splicing events that
can occur in this region. Lower panel: relative quantities of these
variants in a panel of mouse tissues, expressed as a percentage of
total WNK1 expression. Unlike the human situation, exon 26 is
never spliced out of the mouse WNK1 mRNA.
(PDF)
Figure S5 Schematic representation of the localization
of the primers used to determine the relative quantity of
the WNK1 isoforms. The example of region 10–13 is shown.
One of the primers within one pair was designed such that it
overlaps exons that are contiguous only in the isoform of interest.
For example, to study the expression of the ‘‘D11’’ isoform, the
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PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e37751forward primer recognises a sequence located in exon 10 while the
reverse primer overlaps exons 10 and 12.
(PDF)
Table S1 Relative quantities of WNK1 isoforms in a panel of
human tissues.
(PDF)
Table S2 Relative quantities of WNK1 isoforms in a panel of
mouse tissues. * Spinal cord samples also contain the Dorsal Root
Ganglia.
(PDF)
Table S3 Relative quantities of L-WNK1 and KS-WNK1 in
microdissected mouse nephron segments. [L-WNK1]Q and [KS-
WNK1]Q are the values of the ratio of each transcript over exon 8,
given by the 2
2DCT formula. [L-WNK1] and [KS-WNK1] are the
‘‘true’’ expression ratio. a and b are the calculated correction
factors. The ratios given here, being expressed over exon 8,
represent the proportion of L-or KS-WNK1 amongst all WNK1
transcripts. Glom: Glomerulus - PCT: Proximal Convoluted
Tubule - cPR: cortical Pars Recta - mPR: medullary Pars Recta
- mTAL: medullary Thick Ascending Limb of Henle’s loop -
cTAL: cortical Thick Ascending Limb of Henle’s loop - DCT:
Distal Convoluted Tubule - CNT: Connecting tubule - CCD:
cortical Collecting Duct - OMCD: Outer Medullary Collecting
Duct.
(PDF)
Table S4 Sequence of all primers used in this study.
(XLS)
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